Merck, a leading science and technology company, has announced that it has signed a license agreement providing Evo...
France based Vygon Group, a specialist single-use medical devices group, is organizing a number of awareness events in h...
Abbott has announced that a team of its scientists identified a new subtype of the human immunodeficiency virus (HIV), c...
PromoCell, a Germany based premier manufacturer of human primary cells and cell culture products, now offers cell diseas...
Merck has launched its Parteck® COAT excipient, a new functional material designed for immediate release f...
Merck has developed a new filtration-based manufacturing process resulting in a new, highly purified sucrose grade with ...
Thermo Fisher Scientific, the world leader in serving science, has announced that it is investing nearly $24 millio...
To resounding applause from a record gathering from 11 countries, 32 states and virtually every county in South Carolina...
Cerecin, a global healthcare company focused on developing brain health solutions and therapeutics for patients around t...
The U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application for Fluzone®&n...
Shimmer Research, a global leader in wearable technology for research applications, on 4 Nov 2019, announced that E...
In a move to better serve people living with and without diabetes, Boehringer Ingelheim and Eli Lilly and Company will m...
For the first time, scientists at Newcastle University have found there are at least four versions of primary Sjögr...
Pear Therapeutics, Inc. announced that it has entered into an agreement with Ironwood Pharmaceuticals, Inc. to evaluate ...
AstraZeneca has agreed the sale and licence of the commercial rights to Seroquel (quetiapine fumarate immediat...
In addition to a rapid expansion of bone marrow donor registry, increasing commercialization of cellular therapy and tis...
Merck and Pfizer Inc. on 29 Oct 2019, announced that the European Commission (EC) has approved BAVENCIO® (avelu...
The National Institutes of Health (NIH) plans to invest at least $100 million over the next four years towards an audaci...
